| P50 | author | Valentin Djonov | Q87139139 |
| | Crissy Fellabaum | Q61136078 |
| P2093 | author name string | Nebojsa Arsenijevic | |
| | Vladislav Volarevic | |
| | C Randall Harrell | |
| | Marina Gazdic Jankovic | |
| | Bojana Djokovic | |
| P2860 | cites work | TGF-β signaling via TAK1 pathway: role in kidney fibrosis | Q26824337 |
| | Mechanisms of Cisplatin nephrotoxicity | Q26996320 |
| | Acute nephrotoxicity of cisplatin: molecular mechanisms | Q27011912 |
| | Role of an endoplasmic reticulum Ca2+-independent phospholipase A2 in cisplatin-induced renal cell apoptosis | Q28186521 |
| | The TNF and TNF receptor superfamilies: integrating mammalian biology | Q28203717 |
| | Altered cytokine export and apoptosis in mice deficient in interleukin-1 beta converting enzyme | Q28287610 |
| | Mice deficient in IL-1 beta-converting enzyme are defective in production of mature IL-1 beta and resistant to endotoxic shock | Q28307404 |
| | Gamma-glutamyl transpeptidase-deficient mice are resistant to the nephrotoxic effects of cisplatin | Q28363414 |
| | Attenuation of cisplatin-induced renal injury by inhibition of soluble epoxide hydrolase involves nuclear factor κB signaling | Q28385015 |
| | Circulating mitochondrial DAMPs cause inflammatory responses to injury | Q29614470 |
| | Cellular processing of platinum anticancer drugs | Q29617899 |
| | Monocyte recruitment during infection and inflammation | Q29620067 |
| | IL233, A Novel IL-2 and IL-33 Hybrid Cytokine, Ameliorates Renal injury | Q30252348 |
| | M1 macrophage triggered by Mincle leads to a deterioration of acute kidney injury | Q30274760 |
| | Metabolism of Cisplatin to a nephrotoxin in proximal tubule cells. | Q30310364 |
| | Dendritic cells in acute kidney injury: cues from the microenvironment | Q30422946 |
| | Inhibition of gamma-glutamyl transpeptidase activity by acivicin in vivo protects the kidney from cisplatin-induced toxicity. | Q30465767 |
| | Organic cation transporter 2 mediates cisplatin-induced oto- and nephrotoxicity and is a target for protective interventions | Q30476563 |
| | Renal dendritic cells ameliorate nephrotoxic acute kidney injury | Q33562179 |
| | Differential expression of Toll-like receptors in murine peritoneal macrophages in vitro on treatment with cisplatin | Q80186515 |
| | Endotoxin and cisplatin synergistically induce renal dysfunction and cytokine production in mice | Q80310668 |
| | Tumor necrosis factor-alpha in cisplatin nephrotoxicity: a homebred foe? | Q80540729 |
| | Acute renal failure: determinants and characteristics of the injury-induced hyperinflammatory response | Q83201879 |
| | Nec-1 protects against nonapoptotic cell death in cisplatin-induced kidney injury | Q83283731 |
| | Mechanistic study of BNP7787-mediated cisplatin nephroprotection: modulation of human aminopeptidase N | Q84152756 |
| | Tim-1 promotes cisplatin nephrotoxicity | Q84749297 |
| | Phospholipase A2 inhibits cisplatin-induced acute kidney injury by modulating regulatory T cells by the CD206 mannose receptor | Q87345767 |
| | TLR2 and TLR4 play opposite role in autophagy associated with cisplatin-induced acute kidney injury | Q87942844 |
| | Changes in the mucus barrier during cisplatin-induced intestinal mucositis in rats | Q43537138 |
| | Role and regulation of activation of caspases in cisplatin-induced injury to renal tubular epithelial cells | Q43795977 |
| | Cisplatin induces acute renal failure by impairing antioxidant system in guinea pigs: effects of antioxidant supplementation on the cisplatin nephrotoxicity | Q43890992 |
| | Oral erdosteine administration attenuates cisplatin-induced renal tubular damage in rats | Q44288100 |
| | Different mechanisms for gamma-glutamyltransferase-dependent resistance to carboplatin and cisplatin | Q44541803 |
| | Protection of renal cells from cisplatin toxicity by cell cycle inhibitors | Q44579261 |
| | Salicylate reduces cisplatin nephrotoxicity by inhibition of tumor necrosis factor-alpha. | Q44724740 |
| | Caspase-1-deficient mice are protected against cisplatin-induced apoptosis and acute tubular necrosis | Q45166196 |
| | p53-dependent caspase-2 activation in mitochondrial release of apoptosis-inducing factor and its role in renal tubular epithelial cell injury | Q46570433 |
| | Inhibition of p21 modifies the response of cortical proximal tubules to cisplatin in rats | Q46935021 |
| | A pathophysiologic role for T lymphocytes in murine acute cisplatin nephrotoxicity | Q46947114 |
| | Magnesium co-administration decreases cisplatin-induced nephrotoxicity in the multiple cisplatin administration | Q47257329 |
| | Function and regulation of IL-1α in inflammatory diseases and cancer | Q47285901 |
| | TNF-α, IL-6 and IL-10 expressions, responsible for disparity in action of curcumin against cisplatin-induced nephrotoxicity in rats. | Q47840966 |
| | MicroRNA-375 Is Induced in Cisplatin Nephrotoxicity to Repress Hepatocyte Nuclear Factor 1-β. | Q47986520 |
| | Involvement of the CDK2-E2F1 pathway in cisplatin cytotoxicity in vitro and in vivo. | Q50469558 |
| | Autophagy guards against cisplatin-induced acute kidney injury. | Q50503908 |
| | Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer. | Q50512108 |
| | The leukotriene B4-leukotriene B4 receptor axis promotes cisplatin-induced acute kidney injury by modulating neutrophil recruitment. | Q52781114 |
| | Induction of renal endonuclease G by cisplatin is reduced in DNase I-deficient mice. | Q53536393 |
| | Nephroprotective effects of hydration with magnesium in patients with cervical cancer receiving cisplatin. | Q53549841 |
| | Cisplatin-induced acute renal failure is associated with an increase in the cytokines interleukin (IL)-1beta, IL-18, IL-6, and neutrophil infiltration in the kidney. | Q53562266 |
| | The role of toll-like receptor 4 in cisplatin-induced renal injury. | Q53565804 |
| | Cisplatin increases TNF-alpha mRNA stability in kidney proximal tubule cells. | Q53592843 |
| | Endoplasmic reticulum stress-associated caspase 12 mediates cisplatin-induced LLC-PK1 cell apoptosis. | Q53675236 |
| | TNFR2-mediated apoptosis and necrosis in cisplatin-induced acute renal failure. | Q53923667 |
| | Neutrophils in cisplatin AKI-mediator or marker? | Q53965817 |
| | Poly(ADP-ribose) polymerase 1 activation is required for cisplatin nephrotoxicity. | Q54522113 |
| | Interleukin-6 plays a protective role in development of cisplatin-induced acute renal failure through upregulation of anti-oxidative stress factors. | Q54590119 |
| | Necroptosis in Acute Kidney Injury. | Q54977520 |
| | Cisplatin-Induced Rodent Model of Kidney Injury: Characteristics and Challenges | Q57112108 |
| | Interleukin-10 inhibits ischemic and cisplatin-induced acute renal injury | Q58376211 |
| | Mechanisms of death induced by cisplatin in proximal tubular epithelial cells: apoptosis vs. necrosis | Q71897382 |
| | Protective effects of vitamin E and C on cisplatin nephrotoxicity in developing rats | Q73862978 |
| | Cisplatin-induced apoptosis by translocation of endogenous Bax in mouse collecting duct cells | Q74613490 |
| | Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer | Q77321076 |
| | Modulation of platinum-induced toxicities and therapeutic index: mechanistic insights and first- and second-generation protecting agents | Q77448244 |
| | Role of cytochrome P-450 as a source of catalytic iron in cisplatin-induced nephrotoxicity | Q77650651 |
| | Cisplatin-induced nephrotoxicity is mediated by tumor necrosis factor-alpha produced by renal parenchymal cells | Q80066103 |
| | The pathological role of Bax in cisplatin nephrotoxicity | Q80101271 |
| | Induction chemotherapy for head and neck cancer: recent data | Q33734261 |
| | Pathophysiology of cisplatin-induced acute kidney injury | Q34073302 |
| | Cellular Responses to Cisplatin‐Induced DNA Damage | Q34089685 |
| | Cisplatin in cancer therapy: molecular mechanisms of action | Q34098163 |
| | MicroRNA-34a is induced via p53 during cisplatin nephrotoxicity and contributes to cell survival | Q34112716 |
| | Magnesium supplementation and high volume hydration reduce the renal toxicity caused by cisplatin-based chemotherapy in patients with lung cancer: a toxicity study. | Q34748754 |
| | Novel role of base excision repair in mediating cisplatin cytotoxicity | Q34800428 |
| | Toxicity of platinum compounds | Q35143947 |
| | Long-term complications of chemotherapy for germ cell tumours | Q35187360 |
| | Endogenous IL-10 attenuates cisplatin nephrotoxicity: role of dendritic cells | Q35205227 |
| | Dependence of cisplatin-induced cell death in vitro and in vivo on cyclin-dependent kinase 2 | Q35220766 |
| | Chemotherapy in advanced bladder cancer: current status and future | Q35227771 |
| | Poly(ADP-ribose) polymerase-1 is a key mediator of cisplatin-induced kidney inflammation and injury | Q35514172 |
| | Endometrial Carcinoma: A Review of Chemotherapy, Drug Resistance, and the Search for New Agents | Q35583750 |
| | Gene therapy: how to target the kidney. Promises and pitfalls | Q35698689 |
| | Mast cells mediate acute kidney injury through the production of TNF. | Q35758258 |
| | IL-33 exacerbates acute kidney injury | Q35758456 |
| | Application of decoy oligodeoxynucleotides-based approach to renal diseases | Q35971961 |
| | Dendritic Cell Protection from Cisplatin Nephrotoxicity Is Independent of Neutrophils | Q35996641 |
| | Prospective therapeutic applications of p53 inhibitors | Q36113115 |
| | A Systematic Review of Strategies to Prevent Cisplatin-Induced Nephrotoxicity. | Q36355684 |
| | Cellular response to endoplasmic reticulum stress: a matter of life or death | Q36362409 |
| | Autophagy in proximal tubules protects against acute kidney injury | Q36377375 |
| | Hydration with magnesium and mannitol without furosemide prevents the nephrotoxicity induced by cisplatin and pemetrexed in patients with advanced non-small cell lung cancer | Q36424378 |
| | Endogenous Toll-Like Receptor 9 Regulates AKI by Promoting Regulatory T Cell Recruitment | Q36624633 |
| | TLR4 signaling mediates inflammation and tissue injury in nephrotoxicity | Q36662114 |
| | AP214, an analogue of alpha-melanocyte-stimulating hormone, ameliorates sepsis-induced acute kidney injury and mortality | Q36681505 |
| | Mitochondria as a critical target of the chemotheraputic agent cisplatin in head and neck cancer. | Q36743607 |
| | Tumor necrosis factor-α: regulation of renal function and blood pressure | Q36836229 |
| | Proximal tubule-targeted heme oxygenase-1 in cisplatin-induced acute kidney injury | Q36904744 |
| | Cisplatin nephrotoxicity: a review | Q36910929 |
| | Cisplatin nephrotoxicity: mechanisms and renoprotective strategies | Q37084089 |
| | The copper transporter Ctr1 contributes to cisplatin uptake by renal tubular cells during cisplatin nephrotoxicity | Q37138812 |
| | Phase II study of low-dose paclitaxel and cisplatin as a second-line therapy after 5-fluorouracil/platinum chemotherapy in gastric cancer | Q37222473 |
| | Regulation and pathological role of p53 in cisplatin nephrotoxicity | Q37235870 |
| | Gender difference in Cisplatin-induced nephrotoxicity in a rat model: greater intensity of damage in male than female | Q37316465 |
| | Contribution of organic cation transporter 2 (OCT2) to cisplatin-induced nephrotoxicity | Q37353430 |
| | Chemotherapy-induced bone marrow nerve injury impairs hematopoietic regeneration. | Q37660869 |
| | Mediators of inflammation in acute kidney injury | Q37698228 |
| | Cisplatin rescue therapy: experience with sodium thiosulfate, WR2721, and diethyldithiocarbamate | Q37903232 |
| | Cisplatin-induced nephrotoxicity and targets of nephroprotection: an update | Q37989844 |
| | Onco-nephrology: renal toxicities of chemotherapeutic agents | Q38033523 |
| | Treatment of non-small cell lung cancer (NSCLC). | Q38150348 |
| | Chemotherapy advances in small-cell lung cancer | Q38155856 |
| | Membrane transporters as mediators of cisplatin side-effects | Q38176883 |
| | Immune cells in experimental acute kidney injury | Q38261586 |
| | Controversial role of gamma-glutamyl transferase activity in cisplatin nephrotoxicity | Q39012156 |
| | Xenobiotic transporters and kidney injury | Q39098252 |
| | Cisplatin nephrotoxicity: a review of the literature | Q39223600 |
| | Protecting cisplatin-induced nephrotoxicity with cimetidine does not affect antitumor activity | Q39636023 |
| | Disruption of multidrug and toxin extrusion MATE1 potentiates cisplatin-induced nephrotoxicity | Q39660260 |
| | TNF-alpha mediates chemokine and cytokine expression and renal injury in cisplatin nephrotoxicity | Q39738416 |
| | Autophagy is cytoprotective during cisplatin injury of renal proximal tubular cells | Q39977465 |
| | Autophagy is associated with apoptosis in cisplatin injury to renal tubular epithelial cells | Q40015691 |
| | Transcriptional activation of caspase-6 and -7 genes by cisplatin-induced p53 and its functional significance in cisplatin nephrotoxicity | Q40038493 |
| | Characterization of mitochondria in cisplatin-resistant human ovarian carcinoma cells | Q40224571 |
| | Regulation of PUMA-alpha by p53 in cisplatin-induced renal cell apoptosis. | Q40313668 |
| | Regulation of TauT by cisplatin in LLC-PK1 renal cells | Q40412436 |
| | Identification of the functional domain of p21(WAF1/CIP1) that protects cells from cisplatin cytotoxicity | Q40433093 |
| | Effects of sodium thiosulfate versus observation on development of cisplatin-induced hearing loss in children with cancer (ACCL0431): a multicentre, randomised, controlled, open-label, phase 3 trial | Q40443233 |
| | p38 MAP kinase inhibition ameliorates cisplatin nephrotoxicity in mice. | Q40460320 |
| | gamma-Glutamyl transpeptidase catalyses the extracellular detoxification of cisplatin in a human cell line derived from the proximal convoluted tubule of the kidney | Q40653504 |
| | Amifostine pretreatment for protection against cyclophosphamide-induced and cisplatin-induced toxicities: results of a randomized control trial in patients with advanced ovarian cancer | Q40666961 |
| | Roles of toll-like receptors in C-C chemokine production by renal tubular epithelial cells | Q40712456 |
| | Manganese superoxide dismutase attenuates Cisplatin-induced renal injury: importance of superoxide. | Q40765619 |
| | A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy | Q40929887 |
| | Protection from toxicant-mediated renal injury in the rat with anti-CD54 antibody | Q41687992 |
| | AMP-activated protein kinase regulates autophagic protection against cisplatin-induced tissue injury in the kidney | Q41916518 |
| | Role of IL-1α in cisplatin-induced acute renal failure in mice | Q42025525 |
| | CD4+CD25+ regulatory T cells attenuate cisplatin-induced nephrotoxicity in mice | Q42171670 |
| | Innate IL-17A-producing leukocytes promote acute kidney injury via inflammasome and Toll-like receptor activation | Q42223932 |
| | Urinary parameters predictive of cisplatin-induced acute renal injury in dogs | Q42960046 |
| | Esophageal cancer chemotherapy: recent advances. | Q43194164 |
| | Mast cell-derived tumour necrosis factor-alpha mediates macrophage inflammatory protein-2-induced recruitment of neutrophils in mice | Q43261409 |
| | Mechanistic study of BNP7787-mediated cisplatin nephroprotection: modulation of gamma-glutamyl transpeptidase | Q43284420 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | inflammation | Q101991 |
| | signal transduction | Q828130 |
| | kidney | Q9377 |
| P304 | page(s) | 25 | |
| P577 | publication date | 2019-03-13 | |
| P1433 | published in | Journal of Biomedical Science | Q15759332 |
| P1476 | title | Molecular mechanisms of cisplatin-induced nephrotoxicity: a balance on the knife edge between renoprotection and tumor toxicity | |
| P478 | volume | 26 | |